Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?
• Comparative effectiveness and safety results of GLP-1 receptor agonists (Lira vs. Lixi) in routine clinical practice. • Additional Liraglutide effects beyond glycated haemoglobin registered through continuous glucose monitoring system. • Antidiabetic treatment modifications when adding GLP-1 recep...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
|
|---|
| 1. Verfasser: |
Moreno-Fernandez, Jesus
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Garcia-Seco, Jose Alberto
(BerichterstatterIn),
Seco Segura, Angela Maria
(BerichterstatterIn),
Garcia-Seco, Fernando
(BerichterstatterIn),
Rozas Moreno, Pedro Jesus
(BerichterstatterIn),
Aguirre Sanchez-Covisa, Miguel
(BerichterstatterIn) |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2020
|
|---|
| Zugriff auf das übergeordnete Werk: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|
|---|
| Schlagworte: | Obesity
GLP-1 receptor agonists
Routine clinical practice
Type 2 diabetes mellitus
Liraglutide
Lixisenatide |
|---|
| Umfang: | 7 |
|---|